SGLT 2 INHIBITORS: NEWER PARADIGMS IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION
9 Downloads
59 Views
Abstract
Heart Failure is a growing concern now a days. Many drugs are available for the treatment of heart failure but still there is increasing prevalence of heart failure. SGLT 2 inhibitors were initially developed for diabetes mellitus but they are found to be effective for Heart Failure with reduced ejection also. Many large scale randomized controlled trials also confirmed this and now they are recommended in the treatment of heart failure with reduced ejection fraction.
How to Cite This Article
Shaista Alvi (2021); SGLT 2 INHIBITORS: NEWER PARADIGMS IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION, International Journal of Advanced Research (IJAR), 9 (11), 1043-1046, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/13838
Corresponding Author
Article Analytics
This work is licensed under a Creative Commons Attribution 4.0 International License.





